Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 6,254 | 5,320 | 5,024 | 2,891 | 2,753 |
| Operating Income | -6,254 | -5,320 | -5,024 | -2,891 | -2,753 |
| Interest Expense | 480 | 0 | 0 | 0 | 17 |
| Other Income | 0 | 216 | -12 | -77 | 0 |
| Pre-tax Income | -6,734 | -5,104 | -5,036 | -2,968 | -2,770 |
| Income Tax | -544 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -6,190 | -5,104 | -5,036 | -2,968 | -2,770 |
| Net Income | $-6,190 | $-5,104 | $-5,036 | $-2,968 | $-2,770 |
| EPS Basic Total Ops | -2.16 | -1.79 | -1.86 | -1.04 | -1.02 |
| EPS Basic Continuous Ops | -2.17 | -1.79 | -1.88 | -1.04 | -1.02 |
| EPS Diluted Total Ops | -2.16 | -1.79 | -1.86 | -1.04 | -1.02 |
| EPS Diluted Continuous Ops | -2.17 | -1.79 | -1.88 | -1.04 | -1.02 |
| EBITDA(a) | $-6,240 | $-5,307 | $-5,013 | $-2,882 | $-2,746 |